Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Thalassemia 1Primary Myelofibrosis 1Polycythemia Vera 1Leukemia, Myeloid, Acute 1Graft vs Host Disease 1Bronchiolitis Obliterans Syndrome 1

Interventions

ruxolitinib 4venetoclax 1veliparib 1pevonedistat 1navitoclax 1givinostat hydrochloride 1givinostat 1fludarabine phosphate 1elotuzumab 1bomedemstat 1Whole-Body Irradiation 1Valganciclovir 1Topotecan 1Therapeutics 1Tacrolimus 1Sirolimus 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Panobinostat 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Hydroxyurea 1Ganciclovir 1Foscarnet 1Flow Cytometry 1Etoposide 1Drug Evaluation 1Cyclosporine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Polycythemia Vera × Panobinostat × Clear all
NCT02386800 2026-05-27

CINC424A2X01B Rollover Protocol

Novartis

Phase 4 Active not recruiting
279 enrolled
MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Polycythemia Vera, Thalassemia, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡